|Articles|October 18, 2021
Analysis of mRNA Poly-A Sequence Variants by High-Resolution LC–MS
Author(s)Agilent Technologies
The urgency caused by the SARS-CoV-2 pandemic of 2020 prompted policy makers and pharmaceutical firms alike to develop and deploy mRNA vaccines with unprecedented speed.
Newsletter
Get essential updates on the latest spectroscopy technologies, regulatory standards, and best practices—subscribe today to Spectroscopy.
